PGR and cancer: These Prox1-mediated effects were observed both on a cell line positive for estrogen and progesterone receptors (MCF7), representing a non-highly metastatic cancer model, and in a triple-negative cell line for all three hormone receptors (MDA-MB-231), constituting a much more aggressive model system [52,53,54].